Randal K. Wada, MD, MS, FAAP

Randal K. Wada, MD, MS, FAAP

This email address is being protected from spambots. You need JavaScript enabled to view it. | (808) 956-9829

Core Clinical Member, Translational and Clinical Research, University of Hawaiʻi Cancer Center

Academic Appointment(s):
Professor, Nancy Atmospera-Walch School of Nursing, University of Hawaiʻi at Mānoa
Professor and Chief, Division of Hematology/Oncology, Department of Pediatrics, John A. Burns School of Medicine

MD, Emory University
MS, Biological Sciences, Northwestern University

Pediatric Internship and Residency Children's Hospital of Los Angeles
Pediatric Hematology/Oncology clinical fellowship, David Geffen School of Medicine at UCLA
Cancer Immunology and Biology post-doctoral fellowship, David Geffen School of Medicine at UCLA


American Board of Pediatrics, Sub-Board Hematology/Oncology

Research Focus

Interprofessional teamwork and advance care planning; molecular targeting/precision medicine clinical trials.

Selected Publications

Byron SA, Hendricks WPD, Nagulapally AB, Kraveka JM, Ferguson WS, Brown VI, Eslin DE, Mitchell D, Cornelius A, Roberts W, Isakoff MS, Oesterheld JE, Wada RK, Rawwas J, Neville K, Zage PE, Harrod VL, Bergendahl G, VanSickle E, Dykema K, Bond J, Chou HC, Wei JS, Wen X, Reardon HV, Roos A, Nasser S, Izatt T, Enriquez D, Hegde AM, Cisneros F, Christofferson A, Turner B, Szelinger S, Keats JJ, Halperin RF, Khan J, Saulnier Sholler GL, Trent JM. (2021). Genomic and transcriptomic analysis of relapsed and refractory childhood solid tumors reveals a diverse molecular landscape and mechanisms of immune evasion. Cancer Res. Epub ahead of print

Wada RK. (2020). Leadership, behavioral science, and interprofessional teamwork. Transl Behav Med;10:905-908.

Lewis EC, Kraveka JM, Ferguson W, Eslin D, Brown VI, Bergendahl G, Roberts W, Wada RK, Oesterheld J, Mitchell D, Foley J, Zage P, Rawwas J, Rich M, Lorenzi E, Broglio K, Berry D, Saulnier Sholler GL. (2020). A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma. Int J Cancer;147:3152-3159.

Wada RK, Wong L, Flohr A, Kurahara D, Arndt R, Deutsch MJ, Ing D, Richardson K, Munro A, Kaneshige L, Mullis M, Hatae M, Albright CL. (2019). Engaging a community chaplaincy resource for interprofessional health care provider training in facilitating family decision making for children at end-of-life. Hawaii J Med Public Health;78 (Suppl 1):37-40.

Saulnier Sholler GL, Ferguson W, Bergendahl G, Bond JP, Neville K, Eslin D, Brown V, Roberts W, Wada RK, Oesterheld J, Mitchell D, Foley J, Parikh NS, Eshun F, Zage P, Rawwas J, Sencer S, Pankiewicz D, Quinn M, Rich M, Junewick J, Kraveka JM, on behalf of the Beat Childhood Cancer Consortium. (2018). Maintenance DFMO Increases Survival in High Risk Neuroblastoma. Sci Rep; 27:14445.

Publication list via PubMed

Active Grants

R. Wada, PI
Hyundai Hope on Wheels Foundation
Pediatric Oncology Impact Grant
12/01/2021 – 12/31/2022